hydration benefits glp-1 receptor agonist therapy agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity Benefits and drawbacks of GLP-1
Description
Risk of stability and dosing accuracy GLP-1 receptor agonist medications are typically available in pre-filled injection form to deliver a precise dose
and behavioral strategies to support lifestyle change [88]

But how does it do that

Furthermore, in another meta-analysis [23], which excluded ELIXA [24] due to fact that lixisenatide is a short-acting GLP-1RA and all participants had acute coronary syndrome, GLP-1RAs were associated with significant reductions in MACE (HR 0.85, 95% CI 0.800.90), cardiovascular death (HR 0.85, 95% CI 0.780.93), stroke (HR 0.81, 95% CI 0.740.90), and myocardial infarction (HR 0.88, 95% CI 0.810.96) (Table 2)

Tirzepatide is available under FDA-approved prescription uses, while retatrutide is still investigational
